After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
CVS Health Corp is listed on the NYSE in the Healthcare sector while operating in the Healthcare Plans industry. The current market capitalization of CVS Health Corp is $85.42B. A total of 7.36 million shares were traded on the day, compared to an average of 11.17M shares.
In the most recent transaction, Clark James David sold 7,513 shares of CVS for 66.35 per share on Mar 05 ’25. After the transaction, the SVP, Cont & Chief Acct Officer now owns 8,394 company shares. In a previous transaction on Mar 05 ’25, Clark James David bought 7,513 shares at 66.35 per share.
Among the insiders who bought shares, Mahoney Michael F acquired of 30,000 shares on Feb 18 ’25 at a per-share price of $66.70. This resulted in the Director holding 39,356 shares of CVS after the transaction. In another insider transaction, LUDWIG EDWARD J bought 1,000 shares at $53.88 per share on May 02 ’24. Company shares held by the Director now total 21,630.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. CVS Health Corp pays an annual dividend of $2.66, resulting in a dividend yield of 3.93%, and it has a price to earnings (P/E) ratio of 18.53. CVS’s most recent ex-dividend date was 3.89% when it declared a $0.6650 quarterly dividend that was paid in cash on 4/22/2025. Previously, the company paid the dividend on 1/23/2025 with an ex-dividend date of 6.02%. The CVS stock dividend was $0.6650 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CVS has a high of $79.98 and a low of $43.56.
As of this writing, CVS has an earnings estimate of $1.62 per share for the current quarter. EPS was calculated based on a consensus of 21.0 estimates, with a high estimate of $1.96 per share and a lower estimate of $0.97.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CVS’s latest balance sheet shows that the firm has $12.53B in Cash & Short Term Investments as of fiscal 2021. There were $76.00B in debt and $67.81B in liabilities at the time. Its Book Value Per Share was $59.97, while its Total Shareholder’s Equity was $75.38B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CVS is Buy with a score of 4.57.
